Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ATNMActinium Pharmaceuticals, Inc.

NYSE · CIK 0001388320
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts397

Identity from submissions API

NameActinium Pharmaceuticals, Inc.
CIK0001388320
TickersATNM
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN880378336
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(646) 677-3870
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Cactus Ventures, Inc. (2007-02-05T05:00:00.000Z → 2013-03-29T04:00:00.000Z)
Business address
100 PARK AVE., 23RD FLOOR
NEW YORK
NY
10017
NY
Mailing address
100 PARK AVE., 23RD FLOOR
NEW YORK
NY
10017
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

512 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q QUARTERLY REPORT 0001213900-26-120788 001-36374 261562541 34 12549281 1 1
2026-10-16 4 xslF345X06/ownership.xml 0001213900-26-110340 8335
2026-10-16 3 xslF345X06/ownership.xml 0001213900-26-110337 3162
2026-10-15 ARS ARS 0001213900-26-110024 001-36374 261464362 34 1023156
2026-10-15 DEF 14A PROXY STATEMENT 0001213900-26-110022 001-36374 261464355 34 8908559 1 1
2026-10-15 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-26-109884 001-36374 261463641 34 224361 1 1
2026-10-09 S-8 REGISTRATION STATEMENT 0001213900-26-108558 333-299401 261453553 33 385836 1 1
2026-09-10 3 xslF345X06/ownership.xml 0001213900-26-098841 5318
2026-09-10 3 xslF345X06/ownership.xml 0001213900-26-098842 5267
2026-09-04 4 xslF345X06/ownership.xml 0001213900-26-097744 7399
2026-09-04 4 xslF345X06/ownership.xml 0001213900-26-097745 7488
2026-09-04 4 xslF345X06/ownership.xml 0001213900-26-097742 7450
2026-09-04 4 xslF345X06/ownership.xml 0001213900-26-097741 9072
2026-09-04 4 xslF345X06/ownership.xml 0001213900-26-097740 7454
2026-09-04 4 xslF345X06/ownership.xml 0001213900-26-097739 7403
2026-08-14 8-K CURRENT REPORT 3.01,7.01,9.01 0001213900-26-090232 001-36374 261283397 34 259925 1 1
2026-08-07 10-Q QUARTERLY REPORT 0001213900-26-086769 001-36374 261255223 34 10063855 1 1
2026-06-18 8-K CURRENT REPORT 8.01 0001213900-26-070193 001-36374 261103835 34 185726 1 1
2026-05-29 8-K CURRENT REPORT 3.01,7.01,9.01 0001213900-26-062935 001-36374 261045939 34 230949 1 1
2026-05-08 10-Q QUARTERLY REPORT 0001213900-26-053980 001-36374 26959468 34 5209876 1 1
2026-03-30 10-K ANNUAL REPORT 0001213900-26-036504 001-36374 26813843 34 9290028 1 1
2026-03-26 8-K/A AMENDMENT NO.1 TO FORM 8-K 5.07 0001213900-26-034807 001-36374 26799123 34 194902 1 1
2026-02-13 8-K CURRENT REPORT 5.02 0001213900-26-016559 001-36374 26634280 34 190952 1 1
2025-11-26 8-K CURRENT REPORT 5.02,5.07 0001213900-25-115586 001-36374 251531225 34 201877 1 1
2025-11-14 10-Q QUARTERLY REPORT 0001213900-25-110979 001-36374 251487725 34 4880589 1 1
2025-11-05 ARS ARS 0001213900-25-106708 001-36374 251454985 34 1344765
2025-11-05 DEF 14A PROXY STATEMENT 0001213900-25-106706 001-36374 251454963 34 9663457 1 1
2025-08-20 4 xslF345X05/ownership.xml 0001213900-25-079019 5708
2025-08-08 10-Q QUARTERLY REPORT 0001213900-25-073743 001-36374 251199288 34 4387440 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000841 005-82467 251159518 34 6338
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002468 005-82467 251128446 34 10842
2025-05-09 10-Q QUARTERLY REPORT 0001213900-25-041614 001-36374 25931824 34 4227769 1 1
2025-05-09 8-K CURRENT REPORT 4.01,9.01 0001213900-25-041582 001-36374 25931415 34 240091 1 1
2025-04-02 4 OWNERSHIP DOCUMENT 0001213900-25-028232 21147
2025-04-02 4 OWNERSHIP DOCUMENT 0001213900-25-028231 18960
2025-04-02 4 OWNERSHIP DOCUMENT 0001213900-25-028230 5785
2025-04-02 4 OWNERSHIP DOCUMENT 0001213900-25-028228 21243
2025-04-02 4 OWNERSHIP DOCUMENT 0001213900-25-028227 18920
2025-04-02 4 OWNERSHIP DOCUMENT 0001213900-25-028226 21179
2025-04-02 4 OWNERSHIP DOCUMENT 0001213900-25-028225 23367
2025-03-31 10-K ANNUAL REPORT 0001213900-25-026371 001-36374 25794642 34 6759713 1 1
2024-11-27 8-K CURRENT REPORT 5.02,5.07 0001213900-24-103498 001-36374 241511646 34 204476 1 1
2024-11-14 10-Q QUARTERLY REPORT 0001213900-24-098534 001-36374 241463902 34 3851275 1 1
2024-11-12 SC 13G/A UnitedStates_13G__ActiniumPh.txt 0000932471-24-000829 005-82467 241446583 34 6640
2024-11-08 SC 13G/A sc13ga510022atnm_11082024.htm 0000921895-24-002532 005-82467 241442471 34 232100
2024-11-06 ARS FORM ARS 0001213900-24-094762 001-36374 241429244 34 871124
2024-11-05 4 xslF345X05/ownership.xml 0001213900-24-094632 5958
2024-11-05 3 xslF345X02/ownership.xml 0001213900-24-094630 3086
2024-11-05 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-24-094622 001-36374 241428446 34 281625 1 1
2024-11-05 DEF 14A PROXY STATEMENT 0001213900-24-094619 001-36374 241428397 34 5634231
2024-11-04 SC 13G UnitedStates_13G__ActiniumPh.txt 0000932471-24-000238 005-82467 241421679 34 5678
2024-11-04 SC 13G/A UnitedStates_13G__ActiniumPh.txt 0000932471-24-000275 005-82467 241421404 34 5686
2024-08-05 10-Q QUARTERLY REPORT 0001213900-24-065239 001-36374 241176040 34 3644929 1 1
2024-08-05 8-K CURRENT REPORT 7.01,9.01 0001213900-24-064993 001-36374 241173101 34 242458 1 1
2024-04-26 10-Q QUARTERLY REPORT 0001213900-24-036699 001-36374 24884949 34 11136328 1 1
2024-03-29 S-8 REGISTRATION STATEMENT 0001213900-24-028040 333-278395 24804675 33 59368
2024-03-29 10-K ANNUAL REPORT 0001213900-24-028038 001-36374 24804654 34 18254053 1 1
2024-02-09 SC 13G/A sc13ga410022atnm_02092024.htm 0000921895-24-000320 005-82467 24615482 34 241523
2024-02-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-05 16:30:00 9999999995-24-000312 333-273911 24597941 33 1840
2024-02-02 S-3/A PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 0001213900-24-009717 333-273911 24592546 33 618459
2024-02-02 CORRESP filename1.htm 0001213900-24-009720 5567
2024-01-29 SC 13G us00507w2061_012924.txt 0001086364-24-005168 005-82467 24573151 34 13404
2023-12-29 4 xslF345X05/ownership.xml 0001213900-23-100091 5720
2023-12-29 4 xslF345X05/ownership.xml 0001213900-23-100086 5626
2023-12-29 4 xslF345X05/ownership.xml 0001213900-23-100077 5652
2023-12-29 4 xslF345X05/ownership.xml 0001213900-23-100068 5597
2023-12-29 4 xslF345X05/ownership.xml 0001213900-23-100063 5641
2023-12-29 4 xslF345X05/ownership.xml 0001213900-23-100057 5635
2023-12-01 8-K CURRENT REPORT 5.02,5.07 0001213900-23-092089 001-36374 231460343 34 201406 1 1
2023-11-09 ARS FORM ARS 0001213900-23-085309 001-36374 231393703 34 832456
2023-11-09 DEF 14A PROXY STATEMENT 0001213900-23-085303 001-36374 231393633 34 5287437
2023-11-02 10-Q QUARTERLY REPORT 0001213900-23-082459 001-36374 231370325 34 4399862 1 1
2023-08-17 UPLOAD filename1.pdf 0000000000-23-008983 333-273911 40398
2023-08-14 10-Q QUARTERLY REPORT 0001213900-23-067199 001-36374 231171735 34 4262968 1 1
2023-08-11 S-3 REGISTRATION STATEMENT 0001213900-23-065912 333-273911 231161748 33 556886
2023-05-15 10-Q QUARTERLY REPORT 0001213900-23-039902 001-36374 23923954 34 6205378 1 1
2023-03-31 10-K ANNUAL REPORT 0001213900-23-025597 001-36374 23788940 34 8475583 1 1
2023-03-10 8-K CURRENT REPORT 7.01 0001213900-23-019289 001-36374 23724991 34 195649 1 1
2023-02-21 8-K CURRENT REPORT 7.01,9.01 0001213900-23-013059 001-36374 23645216 34 7541404 1 1
2023-02-06 SC 13G/A sc13ga310022atnm_02062023.htm 0000921895-23-000299 005-82467 23591046 34 241468
2022-12-30 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-22-084094 001-36374 221502477 34 220801 1 1
2022-12-09 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-078587 001-36374 221453660 34 24060
2022-12-09 8-K CURRENT REPORT 8.01 0001213900-22-078586 001-36374 221453658 34 195131 1 1
2022-11-21 DEF 14A PROCY STATEMENT 0001213900-22-074269 001-36374 221406557 34 5966093
2022-11-14 10-Q QUARTERLY REPORT 0001213900-22-072371 001-36374 221387244 34 3650021 1 1
2022-10-31 8-K CURRENT REPORT 7.01,9.01 0001213900-22-067378 001-36374 221343770 34 270421 1 1
2022-08-19 S-8 REGISTRATION STATEMENT 0001213900-22-049740 333-266996 221181489 33 191217
2022-08-19 4 xslF345X03/ownership.xml 0001213900-22-049737 4498
2022-08-12 10-Q QUARTERLY REPORT 0001213900-22-047496 001-36374 221161054 34 3866748 1 1
2022-07-01 4 xslF345X03/ownership.xml 0001213900-22-036877 5540
2022-07-01 4 xslF345X03/ownership.xml 0001213900-22-036875 5608
2022-07-01 4 xslF345X03/ownership.xml 0001213900-22-036873 5515
2022-07-01 4 xslF345X03/ownership.xml 0001213900-22-036871 5485
2022-07-01 4 xslF345X03/ownership.xml 0001213900-22-036868 5530
2022-07-01 4 xslF345X03/ownership.xml 0001213900-22-036866 5523
2022-06-29 8-K CURRENT REPORT 1.01,9.01 0001213900-22-035693 001-36374 221051811 34 556165 1 1
2022-06-28 424B3 PROSPECTUS SUPPLEMENT 0001213900-22-035391 333-242322 221046514 33 52255
2022-05-13 10-Q QUARTERLY REPORT 0001213900-22-026538 001-36374 22923765 34 2890770 1 1
2022-04-13 8-K CURRENT REPORT 1.01 0001213900-22-019512 001-36374 22823675 34 195283 1 1
2022-03-25 10-K ANNUAL REPORT 0001213900-22-015208 001-36374 22772177 34 4499003 1 1
2022-02-09 SC 13G/A sc13ga210022002_02092022.htm 0000921895-22-000388 005-82467 22603523 34 241692
2021-11-12 10-Q QUARTERLY REPORT 0001213900-21-058783 001-36374 211404848 34 3346762 1 1
2021-11-09 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-21-057769 001-36374 211393068 34 227026 1 1
2021-11-05 DEFA14A DEFA14A 0001213900-21-056829 001-36374 211381628 34 43105
2021-10-18 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-053318 001-36374 211328911 34 1220030
2021-09-23 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-21-049470 001-36374 211271173 34 297240 1 1
2021-09-03 4 OWNERSHIP DOCUMENT 0001213900-21-046688 5623
2021-09-03 4 OWNERSHIP DOCUMENT 0001213900-21-046687 5653
2021-09-03 4 OWNERSHIP DOCUMENT 0001213900-21-046685 5584
2021-09-03 4 OWNERSHIP DOCUMENT 0001213900-21-046684 5639
2021-09-03 4 OWNERSHIP DOCUMENT 0001213900-21-046683 5614
2021-09-03 4 OWNERSHIP DOCUMENT 0001213900-21-046682 5629
2021-09-03 4 OWNERSHIP DOCUMENT 0001213900-21-046679 5711
2021-07-30 10-Q QUARTERLY REPORT 0001213900-21-039595 001-36374 211133348 34 3417068 1 1
2021-05-14 10-Q QUARTERLY REPORT 0001213900-21-026493 001-36374 21925717 34 2396628 1
2021-03-31 10-K ANNUAL REPORT 0001213900-21-019297 001-36374 21794315 34 3720012 1
2021-02-12 SC 13G/A sc13ga110022atnm_02122020.htm 0000921895-21-000385 005-82467 21628167 34 267476
2021-01-05 SC 13G/A SABBY 13G-A ATNM 1.05.21 0001535610-21-000032 005-82467 21506365 34 13336
2020-11-20 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-20-038523 001-36374 201333262 34 112566
2020-10-28 DEFA14A DEFA14A 0001213900-20-033693 001-36374 201268859 34 200996
2020-10-28 8-K CURRENT REPORT 7.01,9.01 0001213900-20-033692 001-36374 201268820 34 191061
2020-10-23 10-Q QUARTERLY REPORT 0001213900-20-033053 001-36374 201258350 34 2739878 1
2020-10-07 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-20-030520 001-36374 201229582 34 84861
2020-10-07 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-20-030519 001-36374 201229574 34 1373387
2020-08-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-08-14 16:30:00 9999999995-20-002161 333-242322 201107814 33 1798
2020-08-14 4 xslF345X03/ownership.xml 0001213900-20-022342 5600
2020-08-14 4 OWNERSHIP DOCUMENT 0001213900-20-022341 5625
2020-08-14 4 xslF345X03/ownership.xml 0001213900-20-022339 5584
2020-08-14 4 xslF345X03/ownership.xml 0001213900-20-022337 5617
2020-08-14 10-Q QUARTERLY REPORT 0001213900-20-022334 001-36374 201106585 34 2938426 1
2020-08-14 8-K CURRENT REPORT 5.03,8.01,9.01 0001213900-20-022322 001-36374 201106446 34 79466
2020-08-14 4 OWNERSHIP DOCUMENT 0001213900-20-022320 5607
2020-08-14 4 OWNERSHIP DOCUMENT 0001213900-20-022319 5577
2020-08-14 4 xslF345X03/ownership.xml 0001213900-20-022314 5600
2020-08-14 4 xslF345X03/ownership.xml 0001213900-20-022313 5672
2020-08-14 CORRESP filename1.htm 0001213900-20-022138 6060
2020-08-13 UPLOAD filename1.pdf 0000000000-20-007425 40337
2020-08-12 SC 13G sc13g10022act_08112020.htm 0000921895-20-002152 005-82467 201093547 34 283906
2020-08-07 S-3 REGISTRATION STATEMENT 0001213900-20-020895 333-242322 201085235 33 724434
2020-08-05 8-K FORM 8-K 8.01 0001213900-20-020390 001-36374 201078055 34 17995
2020-07-24 8-K CURRENT REPORT 8.01 0001213900-20-018562 001-36374 201047549 34 15230
2020-07-13 10-K/A AMENDMENT NO. 2 TO FORM 10-K 0001213900-20-017370 001-36374 201025766 34 86659
2020-06-29 10-Q QUARTERLY REPORT 0001213900-20-016168 001-36374 20998442 34 2180558 1
2020-06-19 8-K CURRENT REPORT 8.01,9.01 0001213900-20-015376 001-36374 20976558 34 82941
2020-06-18 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-20-015271 001-36374 20973155 34 399045
2020-06-18 424B5 FORM 424B5 0001213900-20-015266 333-216748 20972972 33 1101357
2020-06-16 8-K CURRENT REPORT 8.01 0001213900-20-015114 001-36374 20966842 34 17323
2020-06-16 424B5 PRELIMINARY PROSPECTUS SUPPLEMENT 0001213900-20-015110 333-216748 20966786 33 1101638
2020-06-16 8-K CURRENT REPORT 5.03,9.01 0001213900-20-015104 001-36374 20966730 34 25263
2020-06-16 10-K/A AMENDMENT NO.1 TO FORM 10-K 0001213900-20-015102 001-36374 20966638 34 104857
2020-05-15 8-K FORM 8-K 8.01 0001213900-20-012670 001-36374 20886768 34 18552
2020-05-08 10-K ANNUAL REPORT 0001213900-20-011475 001-36374 20861553 34 3940969 1
2020-05-05 8-K FORM 8-K 5.03,9.01 0001213900-20-011052 001-36374 20850030 34 22431
2020-05-05 8-K CURRENT REPORT 3.01 0001213900-20-011048 001-36374 20849950 34 27355
2020-05-01 SC 13G SABBY 13G ATNM 5.01.20 0001535610-20-000091 005-82467 20838531 34 13382
2020-04-27 SC 13G/A sc13ga210022002_04272020.htm 0000921895-20-001200 005-82467 20820527 34 268047
2020-04-24 8-K CURRENT REPORT 1.01,9.01 0001213900-20-010060 001-36374 20816034 34 438868
2020-04-22 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-009853 333-216748 20808635 33 850610
2020-04-21 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-009696 333-216748 20805178 33 853658
2020-03-27 8-K CURRENT REPORT 8.01 0001213900-20-007702 001-36374 20752628 34 21308
2020-02-14 SC 13G/A sc13ga110022act_02142020.htm 0001193805-20-000221 005-82467 20620062 34 270082
2020-01-08 SC 13G/A SABBY 13G-A ATNM 1.07.20 0001535610-20-000018 005-82467 20514214 34 13382
2019-12-19 8-K CURRENT REPORT 5.07 0001213900-19-026593 001-36374 191296676 34 36403
2019-12-03 8-K FORM 8-K 8.01 0001213900-19-025210 001-36374 191266007 34 21925
2019-11-25 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-19-024628 001-36374 191247049 34 1934953
2019-11-25 8-K CURRENT REPORT 5.02,8.01 0001213900-19-024626 001-36374 191247003 34 27903
2019-11-15 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-19-023769 001-36374 191225336 34 651158
2019-11-12 10-Q QUARTERLY REPORT 0001213900-19-022937 001-36374 191210042 34 2492393 1
2019-10-31 SC 13G sc13g10022act_10302019.htm 0000921895-19-002633 005-82467 191181461 34 286300
2019-08-09 10-Q QUARTERLY REPORT 0001213900-19-015171 001-36374 191013661 34 2254368 1
2019-07-16 4 OWNERSHIP DOCUMENT 0001213900-19-012891 5373
2019-07-16 4 xslF345X03/ownership.xml 0001213900-19-012888 5350
2019-07-16 4 OWNERSHIP DOCUMENT 0001213900-19-012884 5429
2019-07-16 4 xslF345X03/ownership.xml 0001213900-19-012881 5410
2019-07-16 4 OWNERSHIP DOCUMENT 0001213900-19-012879 5454
2019-07-16 4 xslF345X03/ownership.xml 0001213900-19-012875 5379
2019-07-16 4 OWNERSHIP DOCUMENT 0001213900-19-012873 5437
2019-07-16 4 OWNERSHIP DOCUMENT 0001213900-19-012871 5343
2019-07-16 4 OWNERSHIP DOCUMENT 0001213900-19-012869 5470
2019-06-07 8-K CURRENT REPORT 8.01 0001213900-19-010336 001-36374 19886719 34 20228
2019-05-10 10-Q QUARTERLY REPORT 0001213900-19-008291 001-36374 19815764 34 2208142 1
2019-05-10 S-8 REGISTRATION STATEMENT 0001213900-19-008289 333-231391 19815694 33 122086
2019-04-18 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-19-006723 001-36374 19756680 34 620148
2019-04-18 424B5 PRELIMINARY PROSPECTUS SUPPLEMENT 0001213900-19-006717 333-216748 19756568 33 1212608
2019-04-18 SC 13G SABBY 13G ATNM 4.18.19 0001535610-19-000080 005-82467 19755180 34 13388
2019-04-17 424B5 PROSPECTUS SUPPLEMENT 0001213900-19-006578 333-216748 19753215 33 1208606
2019-03-15 10-K ANNUAL REPORT 0001213900-19-004269 001-36374 19685767 34 5284633 1
2019-03-12 8-K CURRENT REPORT 1.01,5.03 0001213900-19-003990 001-36374 19676023 34 18897
2019-03-07 4 xslF345X03/ownership.xml 0001213900-19-003738 4520
2019-02-21 4 xslF345X03/ownership.xml 0001213900-19-002982 4490
2019-02-14 SC 13G/A SC 13G/A 0001193125-19-040177 005-82467 19604253 34 121085
2018-12-28 424B5 PROSPECTUS SUPPLEMENT 0001213900-18-017999 333-216748 181257989 33 565339
2018-12-28 8-K CURRENT REPORT 1.01 0001213900-18-018002 001-36374 181257972 34 16480
2018-12-26 8-K CURRENT REPORT 5.02 0001213900-18-017879 001-36374 181253099 34 16475
2018-12-21 8-K CURRENT REPORT 5.07 0001213900-18-017740 001-36374 181250277 34 26325
2018-12-10 4 xslF345X03/ownership.xml 0001213900-18-017145 4494
2018-12-10 4 xslF345X03/ownership.xml 0001213900-18-017143 4511
2018-11-20 4 OWNERSHIP DOCUMENT 0001213900-18-016321 4534
2018-11-16 DEF 14A PRELIMINARY PROXY STATEMENT 0001213900-18-016080 001-36374 181190474 34 1338057
2018-11-09 10-Q QUARTERLY REPORT 0001213900-18-015315 001-36374 181173837 34 2535635 1
2018-10-30 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-18-014676 001-36374 181147725 34 1084845
2018-10-18 8-K CURRENT REPORT 1.01,9.01 0001213900-18-014103 001-36374 181128886 34 524071
2018-10-18 424B5 PROSPECTUS SUPPLEMENT 0001213900-18-014101 333-216748 181128845 33 614070
2018-08-15 8-K CURRENT REPORT 4.01 0001213900-18-011210 001-36374 181021650 34 20800
2018-08-09 10-Q QUARTERLY REPORT 0001213900-18-010603 001-36374 181006177 34 2523909 1
2018-07-17 4 xslF345X03/ownership.xml 0001213900-18-009327 5437
2018-07-17 4 xslF345X03/ownership.xml 0001213900-18-009325 5349
2018-07-17 4 xslF345X03/ownership.xml 0001213900-18-009324 5379
2018-07-17 4 xslF345X03/ownership.xml 0001213900-18-009320 5424
2018-07-17 4 xslF345X03/ownership.xml 0001213900-18-009317 6913
2018-07-17 4 xslF345X03/ownership.xml 0001213900-18-009315 5411
2018-07-17 4 xslF345X03/ownership.xml 0001213900-18-009314 5310
2018-07-17 4 xslF345X03/ownership.xml 0001213900-18-009311 5340
2018-06-15 4 OWNERSHIP DOCUMENT 0001213900-18-007754 4558
2018-05-10 10-Q QUARTERLY REPORT 0001213900-18-005849 001-36374 18823071 34 1661440 1
2018-05-01 3 OWNERSHIP DOCUMENT 0001213900-18-005263 4466
2018-05-01 8-K CURRENT REPORT 5.02,9.01 0001213900-18-005261 001-36374 18793267 34 203820
2018-04-20 4 OWNERSHIP DOCUMENT 0001213900-18-004773 4540
2018-03-19 4 OWNERSHIP DOCUMENT 0001213900-18-003155 9136
2018-03-16 S-8 REGISTRATION STATEMENT 0001213900-18-003093 333-223741 18696592 33 130283
2018-03-16 10-K ANNUAL REPORT 0001213900-18-003091 001-36374 18696529 34 5064475 1
2018-03-13 SC 13G SC 13G 0001193125-18-080671 005-82467 18686514 34 125621
2018-03-09 8-K CURRENT REPORT 8.01 0001213900-18-002774 001-36374 18680222 34 13848
2018-03-08 4 OWNERSHIP DOCUMENT 0001213900-18-002739 9112
2018-03-08 4 OWNERSHIP DOCUMENT 0001213900-18-002737 9094
2018-03-08 4 OWNERSHIP DOCUMENT 0001213900-18-002730 9099
2018-03-08 4 OWNERSHIP DOCUMENT 0001213900-18-002726 9124
2018-03-01 4 OWNERSHIP DOCUMENT 0001213900-18-002433 4507
2018-02-26 424B5 PROSPECTUS SUPPLEMENT NO. 1 0001213900-18-002272 333-216748 18638820 33 137294
2018-02-26 8-K CURRENT REPORT 5.03,8.01,9.01 0001213900-18-002270 001-36374 18638800 34 148648
2018-02-15 424B5 PROSPECTUS SUPPLEMENT 0001213900-18-001920 333-216748 18616242 33 1210600
2018-02-15 8-K CURRENT REPORT 1.01,9.01 0001213900-18-001918 001-36374 18616179 34 764544
2018-02-14 SC 13G/A d7821437_13g-a.htm 0000919574-18-001673 005-82467 18609167 34 105707
2018-02-13 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-18-000530 005-82467 18598826 34 57862
2018-02-08 3 OWNERSHIP DOCUMENT 0001213900-18-001451 5102
2018-02-08 8-K CURRENT REPORT 1.01,5.02 0001213900-18-001429 001-36374 18582843 34 26516
2018-02-01 424B5 PROSPECTUS SUPPLEMENT 0001213900-18-001166 333-216748 18567823 33 1212732
2018-01-25 8-K CURRENT REPORT 7.01,9.01 0001213900-18-000851 001-36374 18546651 34 1060882
2018-01-09 3 OWNERSHIP DOCUMENT 0001213900-18-000287 4471
2018-01-08 8-K CURRENT REPORT 1.01,5.02 0001213900-18-000252 001-36374 18516769 34 25474
2017-12-21 8-K CURRENT REPORT 5.07 0001213900-17-013528 001-36374 171269617 34 24229
2017-11-14 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-17-012106 001-36374 171202256 34 1662374
2017-11-03 10-Q QUARTERLY REPORT 0001213900-17-011347 001-36374 171176836 34 2971190 1
2017-10-30 PRE 14A PROXY STATEMENT 0001213900-17-011093 001-36374 171163384 34 816241
2017-10-24 424B3 PROSPECTUS 0001213900-17-010873 333-216748 171151244 33 510326
2017-10-24 424B3 PROSPECTUS SUPPLEMENT 0001213900-17-010871 333-216748 171151239 33 217024
2017-10-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-10-12 15:00:00 9999999995-17-002655 333-216748 171135436 33 1798
2017-10-10 CORRESP filename1.htm 0001213900-17-010443 8660
2017-10-05 UPLOAD filename1.pdf 0000000000-17-035472 135596
2017-10-03 CORRESP filename1.htm 0001213900-17-010240 11780
2017-10-03 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-17-010238 333-216748 171117174 33 92336
2017-10-03 CORRESP filename1.htm 0001213900-17-010230 16969
2017-09-26 UPLOAD filename1.pdf 0000000000-17-034181 142419
2017-08-04 SC 13G d7584866_13g.htm 0000919574-17-005752 005-82467 171009337 34 115973
2017-08-04 4 OWNERSHIP DOCUMENT 0001213900-17-008254 4540
2017-08-04 4 OWNERSHIP DOCUMENT 0001213900-17-008246 4538
2017-08-04 10-Q QUARTERLY REPORT 0001213900-17-008244 001-36374 171008872 34 3915054 1
2017-07-31 424B5 PROSPECTUS SUPPLEMENT 0001213900-17-008083 333-194768 17993569 33 960516
2017-07-28 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-17-007992 001-36374 17988027 34 553163 1 1
2017-07-27 424B5 f424b5022717_actiniumphar.htm 0001213900-17-007976 333-194768 17986641 33 946048
2017-07-03 8-K CURRENT REPORT 1.01 0001213900-17-007104 001-36374 17945547 34 16528
2017-07-03 424B5 PROSPECTUS SUPPLEMENT 0001213900-17-007102 333-194768 17945546 33 556746
2017-06-19 3 OWNERSHIP DOCUMENT 0001213900-17-006603 4460
2017-06-16 8-K CURRENT REPORT 1.01,5.02 0001213900-17-006575 001-36374 17916521 34 24399
2017-06-15 4 OWNERSHIP DOCUMENT 0001213900-17-006531 4566
2017-06-15 4 OWNERSHIP DOCUMENT 0001213900-17-006529 6009
2017-06-15 4 OWNERSHIP DOCUMENT 0001213900-17-006527 4556
2017-06-09 8-K CURRENT REPORT 5.02 0001213900-17-006302 001-36374 17903330 34 32867
2017-06-08 8-K CURRENT REPORT 1.01 0001213900-17-006261 001-36374 17900825 34 25493
2017-05-26 8-K/A AMENDMENT TO FORM 8-K 5.02 0001213900-17-005912 001-36374 17874137 34 17935
2017-05-17 3 OWNERSHIP DOCUMENT 0001213900-17-005422 6938
2017-05-16 8-K f8k051217_actiniumpharma.htm 5.02 0001213900-17-005355 001-36374 17848633 34 21517
2017-05-15 10-Q QUARTERLY REPORT 0001213900-17-005183 001-36374 17843135 34 3274626 1
2017-05-11 8-K CURRENT REPORT 1.01,5.02,9.01 0001213900-17-004962 001-36374 17835208 34 36908
2017-05-10 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-17-004886 001-36374 17831344 34 34104
2017-04-05 UPLOAD filename1.pdf 0000000000-17-011459 87293
2017-03-28 3 OWNERSHIP DOCUMENT 0001213900-17-002915 4422
2017-03-28 8-K CURRENT REPORT 5.02,8.01,9.01 0001213900-17-002910 001-36374 17719355 34 284193
2017-03-16 4 OWNERSHIP DOCUMENT 0001213900-17-002501 5496
2017-03-16 S-3 REGISTRATION STATEMENT 0001213900-17-002475 333-216748 17695188 33 1299719
2017-03-16 S-8 REGISTRATION STATEMENT 0001213900-17-002473 333-216746 17695143 33 160152
2017-03-16 4 OWNERSHIP DOCUMENT 0001213900-17-002469 15732
2017-03-16 4 OWNERSHIP DOCUMENT 0001213900-17-002467 5382
2017-03-16 4 OWNERSHIP DOCUMENT 0001213900-17-002465 5488
2017-03-16 10-K ANNUAL REPORT 0001213900-17-002461 001-36374 17694926 34 5574138 1
2017-03-16 4 OWNERSHIP DOCUMENT 0001213900-17-002453 5391
2017-03-16 4 OWNERSHIP DOCUMENT 0001213900-17-002450 5537
2017-03-16 3 OWNERSHIP DOCUMENT 0001213900-17-002448 4495
2017-02-10 SC 13G/A sc13ga110109002_02102017.htm 0000921895-17-000279 005-82467 17594800 34 71635
2017-01-03 4 OWNERSHIP DOCUMENT 0001213900-17-000008 4537
2016-12-22 8-K CURRENT REPORT 5.07 0001213900-16-019608 001-36374 162065091 34 27355
2016-12-14 8-K CURRENT REPORT 1.01,9.01 0001213900-16-019421 001-36374 162051770 34 23352
2016-12-14 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-16-019419 001-36374 162051761 34 14153
2016-12-12 4 OWNERSHIP DOCUMENT 0001213900-16-019329 4541
2016-12-08 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-16-019238 001-36374 162040372 34 27882
2016-11-30 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-16-019059 001-36374 162025455 34 14620
2016-11-18 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-16-018732 001-36374 162008141 34 1786103
2016-10-28 10-Q QUARTERLY REPORT 0001213900-16-017787 001-36374 161959321 34 3368582 1
2016-09-29 424B5 PROSPECTUS SUPPLEMENT 0001213900-16-017150 333-194768 161910560 33 1051836
2016-09-29 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-16-017124 001-36374 161908374 34 456060
2016-09-28 424B5 PRELIMINARY PROSPECTUS SUPPLEMENT 0001213900-16-017084 333-194768 161907071 33 990666
2016-09-15 SC 13G sc13g10109002_09152016.htm 0000921895-16-005695 005-82467 161887191 34 73081
2016-09-01 4 OWNERSHIP DOCUMENT 0000921895-16-005617 25492
2016-08-30 4 OWNERSHIP DOCUMENT 0000921895-16-005607 9210
2016-08-17 4 OWNERSHIP DOCUMENT 0000921895-16-005527 7727
2016-08-04 8-K CURRENT REPORT 7.01,9.01 0001213900-16-015528 001-36374 161805819 34 60896
2016-07-29 10-Q QUARTERLY REPORT 0001213900-16-015402 001-36374 161794615 34 3139942 1
2016-07-14 4 OWNERSHIP DOCUMENT 0000921895-16-005159 6245
2016-07-12 4 OWNERSHIP DOCUMENT 0000921895-16-005149 6245
2016-07-07 4 OWNERSHIP DOCUMENT 0000921895-16-005107 7727
2016-07-05 4 OWNERSHIP DOCUMENT 0000921895-16-005080 38818
2016-07-05 SC 13D/A AMENDMENT NO. 4 TO SCHEDULE 13D 0000921895-16-005079 005-82467 161750980 34 97799
2016-06-17 4 OWNERSHIP DOCUMENT 0000921895-16-004967 4767
2016-06-06 4 OWNERSHIP DOCUMENT 0000921895-16-004862 6260
2016-06-02 4 OWNERSHIP DOCUMENT 0000921895-16-004799 28455
2016-05-31 4 OWNERSHIP DOCUMENT 0000921895-16-004737 7729
2016-05-26 4 OWNERSHIP DOCUMENT 0000921895-16-004701 10689
2016-05-10 10-Q QUARTERLY REPORT 0001213900-16-013129 001-36374 161636151 34 3033095 1
2016-04-26 4 OWNERSHIP DOCUMENT 0000921895-16-004242 28451
2016-04-21 4 OWNERSHIP DOCUMENT 0000921895-16-004207 35859
2016-04-21 SC 13D/A sc13da310109002_04212016.htm 0000921895-16-004206 005-82467 161584538 34 72418
2016-04-18 4 OWNERSHIP DOCUMENT 0001213900-16-012635 7019
2016-04-18 4 OWNERSHIP DOCUMENT 0001213900-16-012634 8406
2016-04-18 4 OWNERSHIP DOCUMENT 0001213900-16-012633 12842
2016-04-18 4 OWNERSHIP DOCUMENT 0001213900-16-012632 5535
2016-04-18 4 OWNERSHIP DOCUMENT 0001213900-16-012631 6921
2016-04-18 4 OWNERSHIP DOCUMENT 0001213900-16-012630 8389
2016-03-11 10-K ANNUAL REPORT 0001213900-16-011534 001-36374 161501685 34 5782491 1
2015-12-24 8-K CURRENT REPORT 1.01,5.07,9.01 0001213900-15-009719 001-36374 151307798 34 204425
2015-12-23 SC 13D/A sc13da210109002_12232015.htm 0000921895-15-002854 005-82467 151306248 34 250526
2015-12-16 8-K CURRENT REPORT 1.01,9.01 0001213900-15-009512 001-36374 151291081 34 23666
2015-11-27 8-K CURRENT REPORT 5.03,8.01,9.01 0001213900-15-009144 001-36374 151258234 34 62391
2015-11-27 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-15-009141 001-36374 151258198 34 35660
2015-11-18 8-K CURRENT REPORT 8.01,9.01 0001213900-15-008841 001-36374 151239128 34 53624
2015-11-12 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-15-008502 001-36374 151225491 34 1038004
2015-10-30 10-Q QUARTERLY REPORT 0001213900-15-008084 001-36374 151187695 34 4147335 1
2015-08-07 10-Q QUARTERLY REPORT 0001213900-15-005829 001-36374 151038081 34 3902243 1
2015-08-03 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-15-005621 001-36374 151021075 34 58180
2015-06-05 8-K CURRENT REPORT 1.01,9.01 0001213900-15-004311 001-36374 15915643 34 346551
2015-06-05 424B5 PRELIMINARY PROSPECTUS SUPPLEMENT 0001213900-15-004303 333-194768 15915208 33 1009579
2015-05-22 4 OWNERSHIP DOCUMENT 0001213900-15-004135 18726
2015-05-22 4 OWNERSHIP DOCUMENT 0001213900-15-004133 8821
2015-05-08 4 OWNERSHIP DOCUMENT 0000921895-15-001232 8973
2015-05-08 10-Q QUARTERLY REPORT 0001213900-15-003401 001-36374 15846714 34 4565462 1
2015-03-17 3 OWNERSHIP DOCUMENT 0001213900-15-001825 7510
2015-03-16 4 OWNERSHIP DOCUMENT 0001213900-15-001820 9234
2015-03-16 4 OWNERSHIP DOCUMENT 0001213900-15-001818 5375
2015-03-16 4 OWNERSHIP DOCUMENT 0001213900-15-001816 5384
2015-03-16 4 OWNERSHIP DOCUMENT 0001213900-15-001810 5421
2015-03-16 4 OWNERSHIP DOCUMENT 0001213900-15-001808 5363
2015-03-16 10-K ANNUAL REPORT 0001213900-15-001800 001-36374 15703038 34 7253224 1
2015-03-04 8-K CURRENT REPORT 5.03,9.01 0001213900-15-001553 001-36374 15673628 34 80246
2015-02-06 424B5 PROSPECTUS SUPPLEMENT 0001213900-15-000794 333-194768 15585728 33 1186854
2015-02-06 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-15-000762 001-36374 15583505 34 351105
2015-02-05 8-K CURRENT REPORT 8.01,9.01 0001213900-15-000744 001-36374 15581169 34 37469
2015-02-05 424B5 PROSPECTUS 0001213900-15-000742 333-194768 15581102 33 1186677
2014-12-24 8-K ACTINIUM PHARMACEUTICALS, INC. FORM 8-K 5.07 0001213900-14-009129 001-36374 141310336 34 24726
2014-12-18 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-15-000008 001-36374 14008669 34 1417
2014-11-14 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-14-008245 001-36374 141224240 34 533430
2014-11-06 8-K ACTINIUM PHARMACEUTICALS, INC. FORM 8-K 7.01,9.01 0001213900-14-007787 001-36374 141198754 34 38391
2014-11-03 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-14-007688 001-36374 141190228 34 541160
2014-10-31 10-Q QUARTERLY REPORT 0001213900-14-007643 001-36374 141186552 34 4547684 1
2014-10-21 8-K CURRENT REPORT 7.01,9.01 0001213900-14-007389 001-36374 141164944 34 6795847
2014-09-25 8-K CURRENT REPORT 7.01,9.01 0001213900-14-006918 001-36374 141121404 34 10075132
2014-09-25 4 OWNERSHIP DOCUMENT 0001213900-14-006917 6733
2014-08-12 10-Q QUARTERLY REPORT 0001213900-14-005682 001-36374 141034499 34 4807697 1
2014-08-04 8-K CURRENT REPORT 7.01,9.01 0001213900-14-005334 001-36374 141011543 34 53063
2014-07-07 S-8 REGISTRATION STATEMENT 0001213900-14-004725 333-197283 14963533 33 1573428
2014-06-25 424B5 PROSPECTUS SUPPLEMENT 0001213900-14-004493 333-194768 14940094 33 1041173
2014-06-25 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-14-004486 001-36374 14938762 34 295339
2014-06-24 424B5 PROSPECTUS SUPPLEMENT 0001213900-14-004469 333-194768 14937661 33 1025761
2014-06-24 8-K CURRENT REPORT 8.01,9.01 0001213900-14-004460 001-36374 14937590 34 44962
2014-06-11 8-K CURRENT REPORT 7.01 0001213900-14-004119 001-36374 14903591 34 91650
2014-05-12 10-Q QUARTERLY REPORT 0001213900-14-003153 001-36374 14834050 34 5149295 1
2014-04-18 424B3 SHELF PROSPECTUS 0001213900-14-002537 333-194768 14772277 33 488935
2014-04-18 424B3 ATM PROSPECTUS 0001213900-14-002535 333-194768 14772272 33 195692
2014-04-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2014-04-17 13:00:00 9999999995-14-001036 333-194768 14771335 33 1778
2014-04-16 CORRESP filename1.htm 0001213900-14-002504 14957
2014-04-10 CORRESP filename1.htm 0001213900-14-002311 23411
2014-04-10 S-3/A REGISTRATION STATEMENT 0001213900-14-002309 333-194768 14757830 33 1779614
2014-04-10 10-K/A AMENDMENT TO ANNUAL REPORT 0001213900-14-002304 001-36374 14757652 34 76861
2014-04-01 UPLOAD filename1.pdf 0000000000-14-016162 162218
2014-03-25 CERTNYS AUTO-GENERATED PAPER DOCUMENT 9999999997-14-004856 001-36374 14005585 34 1379
2014-03-24 8-A12B FORM 8-A 0001213900-14-001685 001-36374 14713994 34 24195
2014-03-24 8-K CURRENT REPORT 8.01,9.01 0001213900-14-001680 000-52446 14713839 34 38729
2014-03-24 8-K CURRENT REPORT 1.01,9.01 0001213900-14-001676 000-52446 14713812 34 26127
2014-03-24 S-3 REGISTRATION STATEMENT 0001213900-14-001672 333-194768 14713776 33 998182
2014-03-19 424B3 PROSPECTUS 0001213900-14-001547 333-193714 14704708 33 1929019
2014-03-19 424B3 PROSPECTUS 0001213900-14-001545 333-191468 14704695 33 3152157
2014-02-28 10-K ANNUAL REPORT 0001213900-14-001206 000-52446 14654952 34 8573632 1
2014-02-20 424B3 PROXY STATEMENT 0001213900-14-001013 333-193714 14627216 33 2719598
2014-02-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2014-02-13 16:30:00 9999999995-14-000450 333-193714 14609257 33 1778
2014-02-12 S-1/A AMENDMENT TO REGISTRATION STATEMENT 0001213900-14-000807 333-193714 14600536 33 11666414 1
2014-02-07 8-K CURRENT REPORT 5.03,9.01 0001213900-14-000688 000-52446 14582156 34 62657
2014-01-31 S-1 REGISTRATION STATEMENT 0001213900-14-000604 333-193714 14565833 33 13390317 1
2014-01-21 D/A xslFormDX01/primary_doc.xml 06b 0001213900-14-000347 021-209458 14538081 33 13212
2014-01-13 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-14-000160 000-52446 14523167 34 62430
2014-01-07 D xslFormDX01/primary_doc.xml 06b 0001213900-14-000064 021-209458 14513489 33 12336
2014-01-03 8-K CURRENT REPORT 1.01,3.02 0001213900-14-000029 000-52446 14505981 34 28823
2013-12-27 8-K CURRENT REPORT 5.07 0001213900-13-007448 000-52446 131300976 34 89779

Latest XBRL company facts

One latest value per concept from companyfacts (397 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 31.44M 2026-11-13 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
dei EntityPublicFloat Entity Public Float USD 43.66M 2025-06-30 2025 FY 10-K 2026-03-30 0001213900-26-036504
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3,869 2025-01-01 2025-12-31 DEF 14A 2026-10-15 0001213900-26-110022
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 546,437 2025-01-01 2025-12-31 DEF 14A 2026-10-15 0001213900-26-110022
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD -658,332 2025-01-01 2025-12-31 DEF 14A 2026-10-15 0001213900-26-110022
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.17M 2024-01-01 2024-12-31 DEF 14A 2026-10-15 0001213900-26-110022
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 47.7 2025-01-01 2025-12-31 DEF 14A 2026-10-15 0001213900-26-110022
ffd NetFeeAmt NetFeeAmt USD 156.6 2026-10-07 S-8 2026-10-09 0001213900-26-108558
ffd TtlFeeAmt TtlFeeAmt USD 156.6 2026-10-07 S-8 2026-10-09 0001213900-26-108558
ffd TtlOfferingAmt TtlOfferingAmt USD 1.80M 2026-10-07 S-8 2026-10-09 0001213900-26-108558
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 237,834 2011-12-31 2012 FY 10-K 2013-03-29 0001213900-13-001417
us-gaap AccountsPayable Accounts Payable (Deprecated 2009-01-31) USD 1,006 2012-03-31 2012 Q1 10-Q 2012-04-23 0001078782-12-001117
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 6.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 378,955 2013-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 0 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 25,000 2017-12-31 2017 FY 10-K 2018-03-16 0001213900-18-003091
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 0 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap AccruedIncomeTaxesPayable Accrued Income Taxes Payable (Deprecated 2009-01-31) USD 0 2012-03-31 2012 Q1 10-Q 2012-04-23 0001078782-12-001117
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1,090 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 868,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -70,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 417.80M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 372,850 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD -207,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 11,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001213900-26-053980
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 52.16M 2020-04-01 2020-06-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058783
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.00M 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap AdvanceRoyalties Advance Royalties USD 35.00M 2022-04-07 2024 Q3 10-Q 2024-11-14 0001213900-24-098534
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 900,000 2000-06-14 2014-03-31 2014 Q1 10-Q 2014-05-12 0001213900-14-003153
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 292,692 2000-06-14 2014-03-31 2014 Q1 10-Q 2014-05-12 0001213900-14-003153
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2,304 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap Assets Assets USD 32.47M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap AssetsCurrent Assets, Current USD 29.49M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap AssetsNoncurrent Assets, Noncurrent USD 0 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 0.33 2012-12-01 2012-12-28 2012 FY 10-K 2013-03-29 0001213900-13-001417
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 16,078 2018-01-01 2018-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 300,000 2019-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap Cash Cash USD 5.88M 2014-03-31 2014 Q1 10-Q 2014-05-12 0001213900-14-003153
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 28.68M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 76.99M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -3.12M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-16 0001213900-18-003091
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 29.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations USD 95.22M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039902
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -19.50M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001213900-25-110979
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -19.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 86.04M 2024-06-30 2024 Q2 10-Q 2024-08-05 0001213900-24-065239
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 5.55 2014-03-31 2014 Q1 10-Q 2014-05-12 0001213900-14-003153
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 11.55 2019-04-23 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 2.30M 2020-06-30 2020 Q2 10-Q 2020-08-14 0001213900-20-022334
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.00B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 31.44M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 31.44M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap CommonStockValue Common Stock, Value, Issued USD 31,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap CommonUnitIssued Common Unit, Issued shares 2,000 2018-12-31 2020 Q3 10-Q 2020-10-23 0001213900-20-033053
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 16.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap ContractualObligation Contractual Obligation USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 35.00M 2025-12-31 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 900,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 124,363 2011-12-31 2012 FY 10-K 2013-03-29 0001213900-13-001417
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap CostOfRevenue Cost of Revenue USD 900,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 16,078 2018-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 4.00M 2012-12-01 2012-12-19 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 1.25M 2012-12-01 2012-12-19 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 103,050 2013-09-30 2013 Q3 10-Q 2013-11-14 0001213900-13-006378
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 372,850 2000-06-14 2014-03-31 2014 Q1 10-Q 2014-05-12 0001213900-14-003153
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.78 2012-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 900,000 2011-12-27 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2011-12-27 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD -150,000 2011-12-27 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DecreaseInRestrictedCash Decrease in Restricted Cash USD 34,733 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-15 0001213900-17-005183
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 252,248 2011-12-31 2012 FY 10-K 2013-03-29 0001213900-13-001417
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 13.80M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 431,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 700,000 2017-08-02 2022 Q2 10-Q 2022-08-12 0001213900-22-047496
us-gaap DeferredRevenue Deferred Revenue USD 8.22M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 100,000 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 35.00M 2024-03-31 2024 Q1 10-Q 2024-04-26 0001213900-24-036699
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 35.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 8.55M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 18.68M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 116.51M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 20.13M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 431,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 62.55M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 44,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 24.81M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 17.88M 2013-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 14,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.21M 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD -1.42M 2013-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 116.08M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 13,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.5 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap DepositAssets Deposit Assets USD 390,940 2018-09-30 2018 Q3 10-Q 2018-11-09 0001213900-18-015315
us-gaap DepositContractsLiabilities Deposit Contracts, Liabilities USD 0 2011-06-30 2012 Q2 10-Q/A 2012-08-29 0001471242-12-001217
us-gaap Deposits Deposits USD 391,131 2018-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 11,350 2014-12-31 2015 FY 10-K 2016-03-11 0001213900-16-011534
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 299,000 2022-06-30 2022 Q2 10-Q 2022-08-12 0001213900-22-047496
us-gaap Depreciation Depreciation USD 173,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 197,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026371
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 679,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 57,212 2017-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 15,916 2017-12-31 2017 FY 10-K 2018-03-16 0001213900-18-003091
us-gaap DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) USD 2.24M 2013-03-31 2013 Q1 10-Q 2013-05-15 0001213900-13-002615
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 304,123 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap DerivativeLiabilities Derivative Liability USD 15,916 2018-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 15,916 2019-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap DerivativeNetAssetsPercentage DerivativeNetAssetsPercentage pure 0.02 2012-06-15 2023 Q3 10-Q 2023-11-02 0001213900-23-082459
us-gaap DevelopmentInProcess Development in Process USD 800,000 2014-06-20 2015 Q2 10-Q 2015-08-07 0001213900-15-005829
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 83.22M 2014-03-31 2014 Q1 10-Q 2014-05-12 0001213900-14-003153
us-gaap Dividends Dividends USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap DividendsCommonStockStock Dividends, Common Stock, Stock USD 1.80M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 10,694 2011-06-30 2012 Q2 10-Q/A 2012-08-29 0001471242-12-001217
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.2 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.05 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent pure 0.042 2012-01-01 2012-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.045 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.062 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.012 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.033 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.8 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.067 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0.21 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 8.80M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1.50M 2020-06-30 2020 Q2 10-Q 2020-08-14 0001213900-20-022334
us-gaap EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost Entertainment, License Agreement for Program Material, Capitalized Cost USD 1.00M 2012-06-15 2023 Q3 10-Q 2023-11-02 0001213900-23-082459
us-gaap EquityFairValueAdjustment Equity, Fair Value Adjustment USD 2.10M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001213900-15-001800
us-gaap EquityFairValueDisclosure Equity, Fair Value Disclosure USD 1,700 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 300,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 2.34 2016-12-31 2016 FY 10-K 2017-03-16 0001213900-17-002461
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.87 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001213900-17-002461
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.009 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001213900-17-002461
us-gaap FairValueInputsProbabilityOfDefault Fair Value Inputs, Probability of Default (Deprecated 2018-01-31) pure 1 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001213900-17-002461
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 18,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 9,000 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 19,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 11,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 11,000 2024-03-31 2024 Q1 10-Q 2024-04-26 0001213900-24-036699
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 11,000 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026371
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 8,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.062 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-04-12 0001078782-12-001008
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -4,122 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-11 0001213900-16-011534
us-gaap GainLossOnDispositionOfProperty Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) USD -554,308 2000-06-14 2013-03-31 2013 Q1 10-Q 2013-05-15 0001213900-13-002615
us-gaap GainLossOnSaleOfProperties Gain (Loss) on Sale of Properties USD 0 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-23 0001078782-12-001117
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 260,000 2000-06-14 2014-03-31 2014 Q1 10-Q 2014-05-12 0001213900-14-003153
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 5.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap Goodwill Goodwill USD 200,000 2017-09-30 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap GrossProfit Gross Profit USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -33.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -598,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap IncomeLossIncludingPortionAttributableToNoncontrollingInterest Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax USD 16.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap IncomeTaxesPaid Income Taxes Paid USD 1,243 2000-06-13 2013-09-30 2013 Q3 10-Q 2013-11-14 0001213900-13-006378
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 5.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 126,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -7.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap IncomeTaxReconciliationNondeductibleExpenseAmortization Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount USD 349,480 2012-01-01 2012-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 1.90M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 2.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 608,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 347,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 16.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap IncomeTaxReconciliationTaxContingenciesForeign Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Amount USD 165.10M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap IncomeTaxReconciliationTaxContingenciesStateAndLocal Effective Income Tax Rate Reconciliation, Tax Contingency, State and Local, Amount USD 283.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -6 2011-10-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -590,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 50,000 2017-01-01 2017-06-30 2018 Q2 10-Q 2018-08-09 0001213900-18-010603
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -234,088 2012-01-01 2012-12-31 2013 FY 10-K 2014-02-28 0001213900-14-001206
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 620 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -731,000 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039902
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -35.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -998,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap IncreaseDecreaseInDueToOtherRelatedParties Increase (Decrease) in Due to Other Related Parties USD 0 2011-10-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 4,040 2011-10-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-04-12 0001078782-12-001008
us-gaap IncreaseDecreaseInNotesPayableRelatedParties Increase (Decrease) in Notes Payable, Related Parties USD -25,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap IncreaseDecreaseInNotesReceivableRelatedParties Increase (Decrease) in Notes Receivable, Related Parties USD 14,689 2011-10-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -528,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 998,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -34,733 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-12 0001213900-14-005682
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 315,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019297
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 1 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -566,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD -299,000 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 356,207 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-16 0001213900-18-003091
us-gaap IndefiniteLivedContractualRights Indefinite-Lived Contractual Rights USD 114.60M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap InterestExpense Interest Expense USD 4,341 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-08-04 0001213900-17-008244
us-gaap InterestExpenseOther Interest Expense, Other USD 5,727 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-08 0001213900-15-003401
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 927,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-04-26 0001213900-24-036699
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 5,007 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 8,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap InterestPayableCurrent Interest Payable, Current USD 24,839 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap InventoryNet Inventory, Net USD 0 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 996,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap InvestmentIncomeNet Investment Income, Net USD 129,549 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001213900-18-015315
us-gaap LeaseCost Lease, Cost USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 7,529 2017-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.50M 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 643,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 380,000 2008-12-31 2023 Q3 10-Q 2023-11-02 0001213900-23-082459
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 380,000 2024-03-31 2024 Q1 10-Q 2024-04-26 0001213900-24-036699
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 380,000 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026371
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 380,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 475,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 83,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap Liabilities Liabilities USD 7.88M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 32.47M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD -10,694 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.37M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 7,529 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap LineOfCredit Long-term Line of Credit USD 390,825 2018-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 900,000 2019-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -18.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 16.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -24.77M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued shares 1.8 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-10-23 0001213900-20-033053
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 996,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap NotesPayableCurrent Notes Payable, Current USD 7.51M 2024-03-31 2024 Q1 10-Q 2024-04-26 0001213900-24-036699
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 53,753 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 72,857 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap NotesReduction Notes Reduction USD 0 2011-10-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD -2,273 2012-07-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap OperatingExpenses Operating Expenses USD 19.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 15.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OperatingLeaseCost Operating Lease, Cost USD 3,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 655,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.42M 2025-03-31 2025 Q1 10-Q 2025-05-09 0001213900-25-041614
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 645,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 510,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OperatingLeasePayments Operating Lease, Payments USD 609,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 191,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001213900-26-053980
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 391,327 2019-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 419,896 2018-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 287,972 2018-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 431,958 2018-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 431,958 2018-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 287,972 2017-12-31 2017 FY 10-K 2018-03-16 0001213900-18-003091
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.06 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 104.80M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 204.60M 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 934,000 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap OtherAssetsCurrent Other Assets, Current USD 168,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap OtherCommitment Other Commitment USD 1.40M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001213900-26-053980
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -50,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -10,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 331 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap OtherFinancialServicesCosts Other Financial Services Costs (Deprecated 2018-01-31) USD 0 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001445305-11-003418
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 2,616 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap OtherIncome Other Income USD 35.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap OtherLiabilities Other Liabilities USD 998,000 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 998,000 2021-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD -1,444 2012-07-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 624,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap OtherRestrictedAssetsCurrent Other Restricted Assets, Current USD 307,000 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap PaymentsForLeasingCosts Payments for Leasing Costs USD 312,660 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap PaymentsForRent Payments for Rent USD 600,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001213900-25-110979
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 600,000 2017-08-02 2022 Q2 10-Q 2022-08-12 0001213900-22-047496
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 207,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap PaymentsToAcquireFinanceReceivables Payments to Acquire Finance Receivables USD 72,696 2019-01-01 2019-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 3.00M 2000-06-14 2014-03-31 2014 Q1 10-Q 2014-05-12 0001213900-14-003153
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 49,859 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 0 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-04-23 0001078782-12-001117
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2017-09-30 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 817,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap PrepaidInsurance Prepaid Insurance USD 591,000 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 800,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 29.10M 2020-04-20 2020-04-24 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 29.25M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan Proceeds from Issuance of Common Stock, Dividend Reinvestment Plan USD 1,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 14.33M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-12 0001213900-14-005682
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 47,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019297
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 35.30M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 390,825 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-16 0001213900-18-003091
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 29.90M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098534
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 14,690 2011-10-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 75,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 47,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap ProfessionalFees Professional Fees USD 13,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -5.13M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001213900-22-026538
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 166,354 2014-09-30 2014 Q3 10-Q 2014-10-31 0001213900-14-007643
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets Property, Plant and Equipment, Net, Excluding Capital Leased Assets USD 906 2017-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap PropertyPlantAndEquipmentOtherAccumulatedDepreciation Property, Plant and Equipment, Other, Accumulated Depreciation USD 694,000 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap RegulatedOperatingRevenueOther Regulated Operating Revenue, Other USD 200,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 381,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2012-01-01 2012-06-30 2012 Q2 10-Q/A 2012-08-29 0001471242-12-001217
us-gaap ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet Research and Development Arrangement with Federal Government, Costs Incurred, Net USD 28.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026371
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 14.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 2.71M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap RestrictedCash Restricted Cash USD 391,000 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 40,105 2019-03-31 2019 Q1 10-Q 2019-05-10 0001213900-19-008291
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 390,940 2018-03-31 2018 Q1 10-Q 2018-05-10 0001213900-18-005849
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 396,000 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 341,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -393.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 100,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 35.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap RevenueNotFromContractWithCustomerOther Revenue Not from Contract with Customer, Other USD 1.03M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-02 0001213900-23-082459
us-gaap Revenues Revenues USD 35.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 30,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026371
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 707,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 9.30M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-06-29 0001213900-20-016168
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 4.50M 2024-06-30 2024 Q2 10-Q 2024-08-05 0001213900-24-065239
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1.90M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 22.5 2017-08-02 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001078782-12-002804
us-gaap SecurityDeposit Security Deposit USD 50,000 2021-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 265,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 5.29M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 25 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001213900-23-082459
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 7.31 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001213900-23-082459
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 5,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.31 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 305,000 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 5.89 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.78 2019-04-01 2019-04-30 2020 FY 10-K 2021-03-31 0001213900-21-019297
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.872 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.817 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 44,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 20 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-23 0001213900-20-033053
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 104 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-14 0001213900-25-110979
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 758,333 2022-12-31 2022 FY 10-K 2023-03-31 0001213900-23-025597
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 3.17M 2024-06-30 2024 Q2 10-Q 2024-08-05 0001213900-24-065239
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 50,000 2026-06-30 2026 Q2 10-Q 2026-08-07 0001213900-26-086769
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.57 2026-06-30 2026 Q2 10-Q 2026-08-07 0001213900-26-086769
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 333,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 4,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001213900-26-086769
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 284,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001213900-26-086769
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.31 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 373,000 2024-01-01 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 379,000 2026-06-30 2026 Q2 10-Q 2026-08-07 0001213900-26-086769
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.99 2026-06-30 2026 Q2 10-Q 2026-08-07 0001213900-26-086769
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.40M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 7.39 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 43.05 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001213900-26-086769
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.15 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001213900-26-086769
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 6.02 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 9.25 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap SharePrice Share Price USD/shares 1.47 2017-09-30 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 500.00M 2023-08-11 2024 Q2 10-Q 2024-08-05 0001213900-24-065239
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 136,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 24.59M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 57.21M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001213900-23-039902
us-gaap StockIssued1 Stock Issued USD 1,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 500,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026371
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 400,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-05-08 0001213900-20-011475
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 21.50M 2017-07-20 2017-08-02 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 547,269 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-10-30 0001213900-15-008084
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 10,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 99,056 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-03 0001213900-17-011347
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 29.25M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 9.79M 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 3.84M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationForfeited Shares Issued, Value, Share-based Payment Arrangement, Forfeited USD 8.80M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0001213900-25-073743
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 3.47M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-16 0001213900-18-003091
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 75,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036504
us-gaap StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) USD 6,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 400,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-06-29 0001213900-20-016168
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 881,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap SubleaseIncome Sublease Income USD 985,000 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-067199
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 17.90M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-15 0001213900-19-004269
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 31.5 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028038
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 31.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 20.57M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015208
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 31.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120788

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →